Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.21 Analyst target: $25.00 Upside: 1966.12%
Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.